DPEP3
gene geneOn this page
Summary
DPEP3 (dipeptidase 3, HGNC:23029) is a protein-coding gene on chromosome 16q22.1, encoding Dipeptidase 3 (Q9H4B8). Lacks dipeptidase activity and is unable to hydrolyze cystinyl-bis-glycine, leukotriene D4 and the beta-lactam antibiotic imipenem.
This gene encodes a membrane-bound glycoprotein from the family of dipeptidases involved in hydrolytic metabolism of various dipeptides, including penem and carbapenem beta-lactam antibiotics. This gene is located on chromosome 16 in a cluster with another member of this family. Alternatively spliced transcript variants that encode different isoforms have been found for this gene.
Source: NCBI Gene 64180 — RefSeq curated summary.
At a glance
- GWAS associations: 23
- Clinical variants (ClinVar): 85 total
- GTEx eGene: eQTL in 6 tissues, sQTL in 2 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.10 (unconstrained)
- MANE Select transcript:
NM_001370198 - Notable: 85 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23029 |
| Approved symbol | DPEP3 |
| Name | dipeptidase 3 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000141096 |
| Ensembl biotype | protein_coding |
| OMIM | 609926 |
| Entrez | 64180 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
MANE Select: ENST00000268793
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 3: 1
ENST00000268793, ENST00000574342, ENST00000672962, ENST00000876631, ENST00001078873, ENST00001132725
RefSeq mRNA: 2 — MANE Select: NM_001370198
NM_001129758, NM_001370198
CCDS: CCDS10856
Canonical transcript exons
ENST00000268793 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000946577 | 67978267 | 67978408 |
| ENSE00000946578 | 67977938 | 67978007 |
| ENSE00000946581 | 67976700 | 67976775 |
| ENSE00000946582 | 67976093 | 67976228 |
| ENSE00001294460 | 67975663 | 67976001 |
| ENSE00001322074 | 67980094 | 67980499 |
| ENSE00001598520 | 67978497 | 67978626 |
| ENSE00001664599 | 67979639 | 67979765 |
| ENSE00001679349 | 67977653 | 67977829 |
| ENSE00001703908 | 67977270 | 67977354 |
Expression profiles
Bgee: expression breadth ubiquitous, 112 present calls, max score 95.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4872 / max 284.0760, expressed in 75 samples.
Highest expression (Bgee): testis, primordial germ cell in gonad, male germ line stem cell (sensu Vertebrata) in testis, sperm, male germ cell.
Genetic regulation across tissues (GTEx eQTL / sQTL)
DPEP3 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 6 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
8 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Whole Blood | eqtl | 5.2e-13 | -0.21 | 16:67964017:T:C |
| Thyroid | eqtl | 5.9e-04 | -0.67 | 16:67182085:T:A |
| Lung | eqtl | 2.1e-03 | +0.64 | 16:67970312:A:G |
| Spleen | sqtl | 3.0e-03 | -1.24 | 16:68361925:G:C |
| Testis | sqtl | 1.4e-02 | -1.28 | 16:68686421:C:T |
| Muscle Skeletal | eqtl | 1.7e-02 | +0.28 | 16:67145070:C:T |
| Adipose Subcutaneous | eqtl | 2.8e-02 | +0.54 | 16:68005937:T:A |
| Adipose Visceral Omentum | eqtl | 4.2e-02 | -1.02 | 16:68462120:G:A |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157842 | 0.3069 | 50 |
| 157841 | 0.1647 | 54 |
| 157840 | 0.0156 | 8 |
Top tissues by expression
showing 100 of 254 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 95.11 | gold quality |
| left testis | UBERON:0004533 | 93.80 | gold quality |
| testis | UBERON:0000473 | 91.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.15 | gold quality |
| sperm | CL:0000019 | 77.02 | silver quality |
| male germ cell | CL:0000015 | 76.44 | silver quality |
| blood | UBERON:0000178 | 75.49 | gold quality |
| adult organism | UBERON:0007023 | 74.46 | gold quality |
| diaphragm | UBERON:0001103 | 70.45 | gold quality |
| granulocyte | CL:0000094 | 70.05 | gold quality |
| triceps brachii | UBERON:0001509 | 69.41 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 65.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 65.46 | gold quality |
| vastus lateralis | UBERON:0001379 | 65.26 | gold quality |
| gluteal muscle | UBERON:0002000 | 64.94 | gold quality |
| spleen | UBERON:0002106 | 64.80 | gold quality |
| biceps brachii | UBERON:0001507 | 64.64 | gold quality |
| quadriceps femoris | UBERON:0001377 | 64.49 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 61.20 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 60.84 | gold quality |
| bone marrow | UBERON:0002371 | 60.31 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 59.15 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 59.10 | gold quality |
| bone marrow cell | CL:0002092 | 58.42 | gold quality |
| decidua | UBERON:0002450 | 57.86 | gold quality |
| superficial temporal artery | UBERON:0001614 | 57.67 | gold quality |
| leukocyte | CL:0000738 | 57.45 | gold quality |
| myocardium | UBERON:0002349 | 57.19 | gold quality |
| deltoid | UBERON:0001476 | 56.77 | gold quality |
| monocyte | CL:0000576 | 56.68 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 56.63 | gold quality |
| mononuclear cell | CL:0000842 | 56.62 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 55.88 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 55.62 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 55.38 | gold quality |
| oral cavity | UBERON:0000167 | 55.24 | gold quality |
| heart right ventricle | UBERON:0002080 | 55.22 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 55.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 55.05 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 54.98 | gold quality |
| globus pallidus | UBERON:0001875 | 54.95 | gold quality |
| saphenous vein | UBERON:0007318 | 54.87 | gold quality |
| medial globus pallidus | UBERON:0002477 | 54.86 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 54.81 | gold quality |
| pons | UBERON:0000988 | 54.75 | gold quality |
| inferior olivary complex | UBERON:0002127 | 54.69 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 53.89 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 53.65 | gold quality |
| lymph node | UBERON:0000029 | 53.51 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 53.47 | gold quality |
| body of tongue | UBERON:0011876 | 53.20 | gold quality |
| superior surface of tongue | UBERON:0007371 | 53.15 | gold quality |
| duodenum | UBERON:0002114 | 53.01 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 52.97 | gold quality |
| tongue | UBERON:0001723 | 52.91 | gold quality |
| parotid gland | UBERON:0001831 | 52.85 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 52.85 | gold quality |
| medulla oblongata | UBERON:0001896 | 52.79 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 52.47 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 52.44 | gold quality |
| thymus | UBERON:0002370 | 52.41 | gold quality |
| small intestine | UBERON:0002108 | 52.34 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 52.23 | gold quality |
| squamous epithelium | UBERON:0006914 | 51.98 | gold quality |
| pericardium | UBERON:0002407 | 51.70 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 51.53 | gold quality |
| synovial joint | UBERON:0002217 | 51.49 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 51.46 | gold quality |
| nipple | UBERON:0002030 | 51.42 | gold quality |
| penis | UBERON:0000989 | 51.39 | gold quality |
| placenta | UBERON:0001987 | 51.33 | silver quality |
| seminal vesicle | UBERON:0000998 | 51.22 | gold quality |
| pylorus | UBERON:0001166 | 51.22 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 51.22 | gold quality |
| renal medulla | UBERON:0000362 | 51.21 | gold quality |
| ventral tegmental area | UBERON:0002691 | 51.13 | gold quality |
| trachea | UBERON:0003126 | 51.09 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 50.99 | gold quality |
| cerebellar vermis | UBERON:0004720 | 50.81 | gold quality |
| vena cava | UBERON:0004087 | 50.63 | gold quality |
| pancreatic ductal cell | CL:0002079 | 50.60 | silver quality |
| right lung | UBERON:0002167 | 50.43 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 50.12 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 50.08 | gold quality |
| caecum | UBERON:0001153 | 49.97 | gold quality |
| cardia of stomach | UBERON:0001162 | 49.84 | gold quality |
| mammalian vulva | UBERON:0000997 | 49.79 | gold quality |
| oocyte | CL:0000023 | 49.68 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 49.57 | gold quality |
| urethra | UBERON:0000057 | 49.57 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 49.33 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 49.18 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 49.11 | gold quality |
| oviduct epithelium | UBERON:0004804 | 49.04 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124263 | yes | 1242.67 |
| E-ANND-3 | no | 0.95 |
HPA expression
RNA tissue specificity: Tissue enriched
59 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 34.8 | high |
| Spleen | tissue | 1.9 | not detected |
| Bone marrow | tissue | 1.6 | not detected |
| Periaqueductal gray | tissue | 1.5 | |
| Basal ganglia | tissue | 1.2 | not detected |
| Hippocampal formation | tissue | 0.9 | |
| Septum | tissue | 0.9 | |
| Cerebral cortex | tissue | 0.8 | not detected |
| Putamen | tissue | 0.8 | |
| Small intestine | tissue | 0.8 | not detected |
| Entorhinal cortex | tissue | 0.8 | |
| Ventral forebrain | tissue | 0.8 | |
| Occipital cortex | tissue | 0.8 | |
| Insular cortex | tissue | 0.8 | |
| Motor cortex | tissue | 0.7 | |
| Amygdala | tissue | 0.7 | |
| Choroid plexus | tissue | 0.7 | |
| Retrosplenial and cingulate cortex | tissue | 0.7 | |
| Somatosensory cortex | tissue | 0.7 | |
| Retrosplenial cortex | tissue | 0.7 | |
| Temporal cortex | tissue | 0.7 | |
| Prefrontal cortex | tissue | 0.6 | |
| Pons | tissue | 0.5 | |
| Tongue | tissue | 0.5 | |
| Hypothalamus | tissue | 0.5 | |
| Olfactory bulb | tissue | 0.5 | |
| Lymph node | tissue | 0.4 | not detected |
| Adipose tissue | tissue | 0.4 | not detected |
| Thalamus | tissue | 0.4 | |
| Cerebellum | tissue | 0.4 | not detected |
| Duodenum | tissue | 0.4 | not detected |
| Corpus callosum | tissue | 0.4 | |
| Stomach 1 | tissue | 0.3 | not detected |
| Midbrain | tissue | 0.3 | |
| Medulla oblongata | tissue | 0.3 | |
| Substantia nigra | tissue | 0.3 | |
| Spinal cord | tissue | 0.3 | |
| Seminal vesicle | tissue | 0.2 | not detected |
| Colon | tissue | 0.2 | not detected |
| Urinary bladder | tissue | 0.2 | not detected |
| Nucleus accumbens | tissue | 0.2 | |
| Superior colliculi | tissue | 0.2 | |
| Lung | tissue | 0.2 | not detected |
| Tonsil | tissue | 0.2 | not detected |
| Appendix | tissue | 0.2 | not detected |
| Heart muscle | tissue | 0.1 | not detected |
| Ovary | tissue | 0.1 | not detected |
| Rectum | tissue | 0.1 | not detected |
| Skeletal muscle | tissue | 0.1 | not detected |
| Pancreas | tissue | 0.1 | not detected |
| Placenta | tissue | 0.1 | not detected |
| Liver | tissue | 0.1 | not detected |
| Gallbladder | tissue | 0.1 | not detected |
| Locus coeruleus | tissue | 0.1 | |
| Hippocampus | tissue | 0.1 | not detected |
| Adrenal gland | tissue | 0.1 | not detected |
| Thymus | tissue | 0.1 | |
| Postcentral gyrus | tissue | 0.1 | |
| Fallopian tube | tissue | 0.1 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 183; highest nTPM — Ventral hippocampus (0.9), Dorsal hippocampus (0.8), Lateral funiculus (white matter) (0.6), Subiculum (0.5), Habenula (0.4).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting DPEP3 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
6 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-1257 | 98.97 | 68.02 | 1133 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-6805-5P | 95.79 | 64.86 | 670 |
Functional genomics
gnomAD constraint: pLI 8.88e-13, LOEUF 1.1, missense Z 1.48 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000268793 — one region, missense o/e 0.88.
Literature-anchored findings (GeneRIF, showing 1)
- This paper describes differences in substrate specificity and tissue distribution of membrane-bound dipeptidase 3 from mouse in comparison to other mouse members of this family. (PMID:12738806)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Dpep3 | ENSMUSG00000031898 |
| rattus_norvegicus | Dpep3 | ENSRNOG00000019757 |
| drosophila_melanogaster | CG6154 | FBGN0039420 |
| drosophila_melanogaster | CG44837 | FBGN0266100 |
Paralogs (2): DPEP1 (ENSG00000015413), DPEP2 (ENSG00000167261)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1919104) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| oligozoospermia | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Coccidioides posadasii C735 delta SOWgp | C5PCN6 | 100.0% | Diamond |
| Coccidioides posadasii str. Silveira | E9CV02 | 100.0% | Diamond |
| Trichophyton benhamiae CBS 112371 | D4B2N2 | 99.5% | Diamond |
| Trichophyton verrucosum HKI 0517 | D4DEJ7 | 99.5% | Diamond |
| Ovis aries | P43477 | 97.3% | Diamond |
| Bos taurus | Q3SZM7 | 97.3% | Diamond |
| Nannizzia gypsea CBS 118893 | E5R2Q7 | 94.2% | Diamond |
| Macaca fascicularis | Q4R7M2 | 93.9% | Diamond |
| Sus scrofa | P22412 | 88.1% | Diamond |
| Microsporum canis CBS 113480 | C5FK77 | 86.5% | Diamond |
| Oryctolagus cuniculus | P31429 | 82.2% | Diamond |
| Uncinocarpus reesii 1704 | C4JQN7 | 78.6% | Diamond |
| Talaromyces stipitatus ATCC 10500 | B8LWT1 | 59.3% | Diamond |
| Fusarium vanettenii 77-13-4 | C7ZIE1 | 59.2% | Diamond |
| Schizosaccharomyces pombe 972h- | O59832 | 54.7% | Diamond |
| Aspergillus oryzae RIB40 | Q2UPB0 | 50.9% | Diamond |
| Aspergillus fumigatus Af293 | Q4WMJ8 | 50.9% | Diamond |
| Aspergillus terreus NIH2624 | Q0CS61 | 50.6% | Diamond |
| Plenodomus lingam | Q6Q886 | 50.3% | Diamond |
| Clonostachys rogersoniana | A0A1U9YI27 | 50.1% | Diamond |
| Claviceps purpurea 20.1 | M1VV65 | 48.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| DPEP2NB | protein-coding | 100131303 |
| DPEP2 | protein-coding | 64174 |
| LCAT | protein-coding | 3931 |
| SLC12A4 | protein-coding | 6560 |
| PSMB10 | protein-coding | 5699 |
| CTRL | protein-coding | 1506 |
| PSKH1 | protein-coding | 5681 |
| NRN1L | protein-coding | 123904 |
Protein
Protein identifiers
Dipeptidase 3 — Q9H4B8 (reviewed: Q9H4B8)
All UniProt accessions (2): A0A5F9ZHB4, Q9H4B8
UniProt curated annotations — full annotation on UniProt →
Function. Lacks dipeptidase activity and is unable to hydrolyze cystinyl-bis-glycine, leukotriene D4 and the beta-lactam antibiotic imipenem. The absence of activity may be due to the inability of asparagine (instead of aspartate found in DPEP1/2) at position 359 to function as the acid/base catalyst and activate the nucleophilic water/hydroxide. A tyrosine (instead of histidine) at position 269 reduces affinity for the beta zinc and may cause substrate steric hindrance.
Subunit / interactions. Homodimer; disulfide-linked. Interacts with TEX101; co-localized on the cell surface of spermatocytes, spermatids, and testicular spermatozoa, co-localized only in cytoplasmic droplets of caput and corpus epididymal sperm.
Subcellular location. Membrane.
Similarity. Belongs to the metallo-dependent hydrolases superfamily. Peptidase M19 family.
RefSeq proteins (2): NP_001123230, NP_001357127* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000180 | Dipep_AS | Active_site |
| IPR008257 | Pept_M19 | Family |
| IPR032466 | Metal_Hydrolase | Homologous_superfamily |
Pfam: PF01244
UniProt features (50 total): helix 21, strand 14, turn 4, disulfide bond 3, sequence conflict 2, signal peptide 1, chain 1, propeptide 1, lipid moiety-binding region 1, glycosylation site 1, mutagenesis site 1
Structure
Experimental structures (PDB)
2 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 6VGO | Crystal Structure of Human Dipeptidase 3 | X-RAY DIFFRACTION | 1.82 |
| 6VGR | Crystal Structure of Human Dipeptidase 3 in Complex with Fab of SC-003 | X-RAY DIFFRACTION | 2.84 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H4B8-F1 | 84.15 | 0.70 |
Antibody-complex structures (SAbDab)
2 antibodies co-crystallized with this protein: 6VGR, TAMRINTAMAB
Human Protein Atlas
Protein class: Metabolic proteins, Predicted membrane proteins, Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1)
| Type | Positions |
|---|---|
| Gpi-anchor amidated serine | 463 |
Disulfide bonds (3)
| Type | Positions |
|---|---|
| Disulfide bond | 146–225, 297–329 |
| Interchain | 434 |
Glycosylation sites (1)
| Type | Positions |
|---|---|
| N-linked (glcnac…) asparagine | 334 |
Mutagenesis-validated functional residues (1)
| Position | Phenotype |
|---|---|
| 196 | loss of zinc binding. |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 92 (showing top):
chr16q22, GOCC_SECRETORY_GRANULE, GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS, GOBP_AMIDE_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_CATABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP, GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS, GOBP_LIPID_CATABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS, GOBP_LEUKOTRIENE_METABOLIC_PROCESS, GOCC_SECRETORY_VESICLE, GOCC_SIDE_OF_MEMBRANE, GOBP_PROTEOLYSIS
GO Biological Process (2): proteolysis (GO:0006508), leukotriene D4 catabolic process (GO:1901749)
GO Molecular Function (3): dipeptidase activity (GO:0016805), peptidase activity (GO:0008233), metallodipeptidase activity (GO:0070573)
GO Cellular Component (4): acrosomal vesicle (GO:0001669), plasma membrane (GO:0005886), membrane (GO:0016020), side of membrane (GO:0098552)
GO top-level categories
14 GO namespaces:
| Category | Terms |
|---|---|
| membrane | 2 |
| cellular anatomical structure | 2 |
| protein metabolic process | 1 |
| leukotriene catabolic process | 1 |
| sulfur compound catabolic process | 1 |
| icosanoid catabolic process | 1 |
| exopeptidase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| metalloexopeptidase activity | 1 |
| dipeptidase activity | 1 |
| secretory granule | 1 |
| cell periphery | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
showing 15 of 868 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DPEP3 | TEX101 | Q9BY14 | 547 |
| DPEP3 | CNDP2 | Q96KP4 | 439 |
| DPEP3 | SMIM12 | Q96EX1 | 396 |
| DPEP3 | SHISA4 | Q96DD7 | 386 |
| DPEP3 | SPACA4 | Q8TDM5 | 377 |
| DPEP3 | BEND7 | Q8N7W2 | 371 |
| DPEP3 | CTSC | P53634 | 368 |
| DPEP3 | ABI3BP | Q7Z7G0 | 365 |
| DPEP3 | XPNPEP2 | O43895 | 364 |
| DPEP3 | CHN2 | P52757 | 362 |
| DPEP3 | LRRC40 | Q9H9A6 | 362 |
| DPEP3 | A0A2R8YEI5 | A0A2R8YEI5 | 362 |
| DPEP3 | MNMIP1 | A4FU49 | 357 |
| DPEP3 | LY6K | Q17RY6 | 348 |
| DPEP3 | AAMDC | Q9H7C9 | 340 |
IntAct
Human interaction partners of DPEP3 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
3 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| HSPA5 | association | 0.530 | 2 |
| TEX101 | proximity | 0.420 | 4 |
| PDIA6 | physical association | 0.400 | 1 |
BioGRID (13 interactions; top human partners by supporting records): DPEP2 (Affinity Capture-MS; 3 records), TEX101 (Affinity Capture-MS; 3 records), CANX (Affinity Capture-MS; 2 records), HSPA5 (Affinity Capture-MS; 2 records), CHD4 (Affinity Capture-MS), EGFR (Affinity Capture-MS), LINC00839 (Protein-RNA)
Ligand–receptor pairs (CellPhoneDB) (2)
Curated ligand–receptor partners (cell-cell communication), distinct from the protein–protein interactions above.
2 ligand–receptor pairs:
| Partner | This gene’s role | Signaling class |
|---|---|---|
| CYSLTR2 | ligand | Signaling by Lipoxin/Leukotriene |
| CYSLTR1 | ligand | Signaling by Lipoxin/Leukotriene |
Disease & clinical
Genetic variants
Variant evidence for DPEP3: 85 ClinVar records (0 pathogenic / likely pathogenic); 23 GWAS associations.
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 4 |
| Benign | 1 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 33 predictions of 795):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 16:67976091–67976092 | donor_loss | 1.0000 | 3 |
| 16:67977936–67977937 | donor_loss | 1.0000 | 4 |
| 16:67978008–67978009 | acceptor_loss | 1.0000 | 4 |
| 16:67978266 | donor_loss | 1.0000 | |
| 16:67978409–67978410 | acceptor_loss | 1.0000 | 5 |
| 16:67976002–67976003 | acceptor_loss | 0.9900 | 2 |
| 16:67976091 | donor_loss | 0.9900 | |
| 16:67977268–67977269 | donor_loss | 0.9900 | 3 |
| 16:67977355–67977356 | acceptor_loss | 0.9900 | 5 |
| 16:67977651–67977652 | donor_loss | 0.9900 | 5 |
AlphaMissense
427 missense substitutions predicted likely pathogenic (of 3,133 scored), across 150 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| W229 | 7 | 0.888 | 0.975 |
| W140 | 7 | 0.842 | 0.972 |
| D266 | 7 | 0.805 | 0.843 |
| W388 | 7 | 0.804 | 0.906 |
| N400 | 7 | 0.800 | 0.914 |
| E257 | 7 | 0.773 | 0.845 |
| C297 | 7 | 0.765 | 0.814 |
| C225 | 7 | 0.759 | 0.829 |
| C146 | 7 | 0.719 | 0.800 |
| D95 | 7 | 0.670 | 0.806 |
| D162 | 7 | 0.640 | 0.729 |
| G215 | 6 | 0.826 | 0.936 |
| C329 | 6 | 0.748 | 0.822 |
| M88 | 6 | 0.745 | 0.821 |
| H341 | 6 | 0.721 | 0.801 |
| C168 | 6 | 0.697 | 0.871 |
| F139 | 5 | 0.906 | 0.939 |
| F250 | 5 | 0.832 | 0.910 |
| G355 | 5 | 0.817 | 0.875 |
| G262 | 5 | 0.790 | 0.919 |
HPA cancer prognostics
RNA cancer specificity: Group enriched (Ovary Serous Cystadenocarcinoma, Skin Cutaneous Melanoma, Testicular Germ Cell Tumor)
Disease associations
OMIM: gene MIM:609926 | disease phenotypes:
GWAS associations
23 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST008084_142 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 2e-99 |
| GCST008075_69 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 5e-81 |
| GCST008085_169 | HDL cholesterol levels in current drinkers | 7e-54 |
| GCST008084_11 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 2e-50 |
| GCST008075_217 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 4e-39 |
| GCST008070_58 | HDL cholesterol levels | 2e-35 |
| GCST008084_110 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 4e-24 |
| GCST008075_8 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 3e-23 |
| GCST008085_35 | HDL cholesterol levels in current drinkers | 3e-23 |
| GCST008084_95 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 5e-19 |
| GCST008070_79 | HDL cholesterol levels | 1e-17 |
| GCST008085_87 | HDL cholesterol levels in current drinkers | 5e-17 |
| GCST008075_44 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 2e-16 |
| GCST010002_165 | Refractive error | 2e-14 |
| GCST008085_75 | HDL cholesterol levels in current drinkers | 3e-14 |
| GCST008084_138 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 3e-11 |
| GCST008075_60 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 1e-10 |
| GCST008070_15 | HDL cholesterol levels | 4e-10 |
| GCST002539_44 | Schizophrenia | 2e-8 |
| GCST006803_78 | Schizophrenia | 4e-8 |
| GCST008085_161 | HDL cholesterol levels in current drinkers | 6e-8 |
| GCST008070_48 | HDL cholesterol levels | 4e-6 |
| GCST008087_136 | Triglyceride levels in current drinkers | 9e-6 |
EFO canonical traits (from GWAS)
3 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004329 | alcohol drinking |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| entinostat | increases expression, affects cotreatment | 2 |
| Air Pollutants | affects expression, increases abundance, increases expression | 2 |
| testosterone enanthate | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| cetrorelix | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Estradiol | affects binding, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Valproic Acid | increases methylation | 1 |
| Desogestrel | affects cotreatment, decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.